...
首页> 外文期刊>Journal of Analytical & Bioanalytical Techniques >Stability Studies of Ternary Mixtures Containing Fosaprepitant,Dexamethasone, Ondansetron and Granisetron Used in Clinical Practice
【24h】

Stability Studies of Ternary Mixtures Containing Fosaprepitant,Dexamethasone, Ondansetron and Granisetron Used in Clinical Practice

机译:临床应用中含有福沙丁胺,地塞米松,昂丹司琼和格兰司琼的三元混合物的稳定性研究

获取原文
           

摘要

The use of a combination of 5HT3 receptor antagonist, a NK-1 receptor antagonist and dexamethasone has been classified to be state of the art in patients receiving highly as well as moderately emetogenic chemotherapy like cisplatin and anthracyclines. The administration of the ad-hoc admixture of fosaprepitant, dexamethasone and ondansetron (FDO) or granisetron (FDG) in the same IV infusion solution will improve the management of ambulatory procedures related to reducing administration time and number of administered intravenous preparations. All this would improve patient safety and comfort. In order to guarantee security of patients and efficacy of treatment, information about physico-chemical stability of both ternary mixtures at concentrations used in routine clinical practice and at different conditions of storage is needed. In this study, physico-chemical stability of ternary mixtures of fosaprepitant (150 mg), dexamethasone (8 mg) and ondansetron (8 mg) or granisetron (3 mg) in 50,100 and 250 ml of 0.9 g/dl NaCl at room temperature/refrigerated and protective from/exposed to light has been evaluated. An HPLC method has been developed and validated according to International Conference on Harmonization guidelines to evaluate chemical stability of drugs in mixtures simultaneously. Physical stability study has been carried out by visual inspection, pH measure and gravimetry to control evaporation. The results shown in this paper represent the first evidence of the physico-chemical stability of both ternary mixtures used in clinical practice at different conditions of storage. The ternary mixtures of FDG in 100 and 250 ml of 0.9 g/dl NaCl are physico-chemical stable for 15 days at room temperature and refrigerated and exposed to and protected from light; mixtures in 50 ml are physico-chemical stable for 6 days. The ternary mixtures of FDO in 50, 100 and 250 ml of 0.9 g/dl NaCl are physico-chemical stable for 15 days at both conditions of temperature and light.
机译:5HT3受体拮抗剂,NK-1受体拮抗剂和地塞米松的联合使用已被归类为接受顺铂和蒽环类抗生素治疗的患者。在同一IV输注溶液中施用福沙普瑞特,地塞米松和恩丹西酮(FDO)或Granisetron(FDG)的临时混合物将改善与缩短给药时间和减少静脉注射制剂数量有关的门诊程序的管理。所有这些将改善患者的安全性和舒适性。为了保证患者的安全性和治疗效果,需要有关两种三元混合物在常规临床实践中使用的浓度和在不同储存条件下的理化稳定性的信息。在这项研究中,室温下,福沙丁胺(150 mg),地塞米松(8 mg)和恩丹西酮(8 mg)或格拉司琼(3 mg)在50,100和250 ml 0.9 g / dl NaCl中的三元混合物的理化稳定性/已评估了冷藏和避光的特性。已经根据国际协调会议指南开发并验证了一种HPLC方法,以同时评估混合物中药物的化学稳定性。通过目视检查,pH测量和重量分析法进行了物理稳定性研究,以控制蒸发。本文显示的结果代表了两种三元混合物在不同储存条件下用于临床实践的理化稳定性的第一个证据。 FDG在100和250 ml的0.9 g / dl NaCl中的三元混合物在室温下物理化学稳定15天,然后冷藏并暴露于光下; 50毫升的混合物理化稳定6天。 FDO在50、100和250 ml 0.9 g / dl NaCl中的三元混合物在温度和光照条件下均保持15天的物理化学稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号